Actavis Recalls Desmopressin Acetate Tablets with Incorrect Imprint
Actavis is recalling 11,445 bottles of Desmopressin Acetate Tablets because some tablets are incorrectly imprinted with an X.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences. The issue is a cosmetic imprint error, not a functional or safety defect.
Plain-English summary
Actavis Laboratories, FL, Inc. is recalling 11,445 bottles of Desmopressin Acetate Tablets, 0.1mg, 100 Count Bottles. The product is distributed nationwide in the U.S., including Puerto Rico. The specific lot number is 982021M, with an expiration date of December 2016.
The recall was initiated because some tablets in the affected lot are incorrectly imprinted with an X on one side. This is a Class III recall, indicating that the product is not likely to cause adverse health consequences.
Consumers who have this product should contact their healthcare provider or pharmacist for guidance on how to proceed. The product is prescription-only, so patients should not attempt to self-manage the recall without professional advice.
The recalled product
- Product
- Desmopressin Acetate Tablets, 0.1mg, 100 Count Bottles, Rx Only. Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA; Distributed by Actavis Pharma, Inc. Parsippany, NJ 07054 USA. NDC: 0591-2464-01.
- Manufacturer
- Actavis Laboratories, FL, Inc.
- Category
- Drug — Tablets
- Hazard
- Affected units
- 11,445
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 982021M
- Expiry: DEC. 2016
Distribution
Related recalls
Same manufacturer · Actavis Laboratories, FL, Inc.
See all →- LowActavis Recalls Ramipril Capsules Due to Incorrect Expiration Date Labeling
FDA (Drugs) · 2016-11-09
- ModerateActavis Recalls Metformin Hydrochloride Extended-Release Tablets for Dissolution Failure
FDA (Drugs) · 2015-10-21
- ModerateActavis Recalls Cartia XT Capsules Due to Aluminum Residue on Exterior
FDA (Drugs) · 2015-04-22
- ModerateActavis Recalls Diclofenac Sodium and Misoprostol Tablets Due to Split Tablets
FDA (Drugs) · 2014-12-03
- ModerateActavis Recalls Diclofenac Sodium and Misoprostol Tablets Due to Splitting
FDA (Drugs) · 2014-10-08
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02